Literature DB >> 16023393

Functional characterization of the E399D DMT1/NRAMP2/SLC11A2 protein produced by an exon 12 mutation in a patient with microcytic anemia and iron overload.

Steven Lam-Yuk-Tseung1, Melissa Mathieu, Philippe Gros.   

Abstract

DMT1 (Nramp2, Slc11a2) mediates iron uptake at the intestinal brush border and across the membrane of acidified endosomes. A single patient with severe microcytic anemia and iron overload was recently reported to carry a mutation in exon 12 of DMT1 (1285G>C). The mutation has two effects: it severely impairs splicing causing skipping of exon 12 and introduces an amino acid polymorphism (E399D) in the protein encoded by the remaining properly spliced transcript found in the patient. The functional properties and possible contribution to disease of the DMT1 E399D mutation are unknown and have been studied in independent mutants at that position (E399D, E399Q, E399A) expressed in LLC-PK1 kidney cells. The 3 mutants are shown to be fully functional with respect to stability, targeting and trafficking to the membrane, and are transport-competent. This indicates that DMT1G1285C is not a complete loss of function but rather that a modest amount of active DMT1 is produced in this patient. This activity may explain the distinguishing iron overload seen in this patient in addition to microcytic anemia that is absent in parallel rodent models of DMT1 deficiency.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16023393     DOI: 10.1016/j.bcmd.2005.05.008

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  11 in total

1.  Belgrade rats display liver iron loading.

Authors:  Khristy Thompson; Ramon M Molina; Joseph D Brain; Marianne Wessling-Resnick
Journal:  J Nutr       Date:  2006-12       Impact factor: 4.798

Review 2.  Manganese transport in eukaryotes: the role of DMT1.

Authors:  Catherine Au; Alexandre Benedetto; Michael Aschner
Journal:  Neurotoxicology       Date:  2008-05-14       Impact factor: 4.294

Review 3.  Molecular basis of inherited microcytic anemia due to defects in iron acquisition or heme synthesis.

Authors:  Achille Iolascon; Luigia De Falco; Carole Beaumont
Journal:  Haematologica       Date:  2009-01-30       Impact factor: 9.941

Review 4.  Iron transport machinery of human cells: players and their interactions.

Authors:  Ningning Zhao; Caroline A Enns
Journal:  Curr Top Membr       Date:  2012       Impact factor: 3.049

Review 5.  H(+)-coupled divalent metal-ion transporter-1: functional properties, physiological roles and therapeutics.

Authors:  Ali Shawki; Patrick B Knight; Bryan D Maliken; Eric J Niespodzany; Bryan Mackenzie
Journal:  Curr Top Membr       Date:  2012       Impact factor: 3.049

6.  Transmembrane helix 6b links proton and metal release pathways and drives conformational change in an Nramp-family transition metal transporter.

Authors:  Aaron T Bozzi; Anne L McCabe; Benjamin C Barnett; Rachelle Gaudet
Journal:  J Biol Chem       Date:  2019-12-27       Impact factor: 5.157

7.  Erythropoietin-driven signaling ameliorates the survival defect of DMT1-mutant erythroid progenitors and erythroblasts.

Authors:  Monika Horvathova; Katarina Kapralova; Zuzana Zidova; Dalibor Dolezal; Dagmar Pospisilova; Vladimir Divoky
Journal:  Haematologica       Date:  2012-05-11       Impact factor: 9.941

Review 8.  Molecular Mechanism of Nramp-Family Transition Metal Transport.

Authors:  Aaron T Bozzi; Rachelle Gaudet
Journal:  J Mol Biol       Date:  2021-04-16       Impact factor: 6.151

Review 9.  Divalent metal transporter 1 (DMT1) in the brain: implications for a role in iron transport at the blood-brain barrier, and neuronal and glial pathology.

Authors:  Tina Skjørringe; Annette Burkhart; Kasper Bendix Johnsen; Torben Moos
Journal:  Front Mol Neurosci       Date:  2015-06-08       Impact factor: 5.639

10.  SMF-1, SMF-2 and SMF-3 DMT1 orthologues regulate and are regulated differentially by manganese levels in C. elegans.

Authors:  Catherine Au; Alexandre Benedetto; Joel Anderson; Arnaud Labrousse; Keith Erikson; Jonathan J Ewbank; Michael Aschner
Journal:  PLoS One       Date:  2009-11-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.